Raaj Medisafe Complete Financial Statements
In FYNone, Raaj Medisafe (RAAJMEDI) reported revenue ₹74 Cr, net profit ₹8 Cr and EPS ₹5.80, with a net profit margin of 9.5% and ROE of 22.2%. Full financial statements from FY2015 to FY2025 (11 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. For live price, earnings ratios and company overview, see RAAJMEDI company profile.
Complete Financial Data Export
Profitability Ratios
Balance Sheet Ratios
RAAJMEDI Revenue, Net Profit & EBITDA — Year-on-Year Growth
RAAJMEDI YoY (March 2025 vs Period) — revenue +17.5%, net profit +33.3%, EBITDA +22.2%, expenses +16.7%.
RAAJMEDI Income Statement — Revenue, EBITDA & Net Profit
Raaj Medisafe revenue ₹74 Cr, EBITDA ₹11 Cr, net profit ₹8 Cr, EPS ₹5.80 (None) — net profit margin 9.5%. Explore RAAJMEDI fundamental worth to estimate fundamental worth using multiple valuation models.
| Particulars | None | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 | March 2019 | March 2018 | March 2017 | March 2016 | March 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 74 | 63 | 43 | 39 | 35 | 32 | 22 | 5 | 5 | 5 | 2 | 0 |
| Expenses | 63 | 54 | 37 | 33 | 30 | 28 | 20 | 6 | 5 | 5 | 2 | 1 |
| EBITDA | 11 | 9 | 7 | 6 | 5 | 4 | 2 | -1 | -1 | 0 | 0 | -1 |
| Operating Profit Margin % | 15.00% | 14.00% | 15.00% | 15.00% | 15.00% | 13.00% | 7.00% | -16.00% | -10.00% | -2.00% | -17.00% | -14441.00% |
| Depreciation | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| Interest | 3 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 |
| Profit Before Tax | 7 | 5 | 4 | 4 | 4 | 3 | 0 | -2 | -1 | -1 | -1 | -1 |
| Tax | 1 | -1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | 8 | 6 | 3 | 3 | 3 | 2 | 0 | -2 | -1 | -1 | -1 | -1 |
| Earnings Per Share (₹) | 5.80 | 4.60 | 3.07 | 3.06 | 2.82 | 2.07 | -0.30 | -3.16 | -2.86 | -1.68 | -2.14 | -2.35 |
RAAJMEDI Balance Sheet — Assets, Liabilities & Shareholders' Equity
RAAJMEDI total assets ₹69 Cr, total equity ₹27 Cr, total liabilities ₹69 Cr (2025) — ROE 22.2%.
| Particulars | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||||
| Total Assets | 69 | 41 | 26 | 20 | 17 | 14 | 5 | 5 | 6 | 5 | 4 |
| Current Assets | 30 | 19 | 15 | 10 | 7 | 6 | 2 | 2 | 2 | 2 | 1 |
| Fixed Assets | 23 | 11 | 9 | 9 | 7 | 7 | 4 | 4 | 4 | 4 | 3 |
| Capital Work in Progress | 9 | 10 | 2 | 0 | 2 | 0 | 0 | 0 | 1 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 38 | 20 | 16 | 10 | 8 | 7 | 2 | 2 | 2 | 2 | 1 |
| LIABILITIES | |||||||||||
| Total Liabilities | 69 | 41 | 26 | 20 | 17 | 14 | 5 | 5 | 6 | 5 | 4 |
| Current Liabilities | 14 | 15 | 7 | 6 | 9 | 8 | 10 | 8 | 8 | 7 | 7 |
| Non-Current Liabilities | |||||||||||
| SHAREHOLDERS' EQUITY | |||||||||||
| Total Equity | 27 | 11 | 8 | 4 | 1 | -1 | -8 | -6 | -5 | -4 | -3 |
| Share Capital | 13 | 11 | 11 | 11 | 11 | 11 | 5 | 5 | 5 | 5 | 5 |
| Reserves & Surplus | 14 | 0 | -3 | -7 | -10 | -12 | -13 | -11 | -10 | -9 | -8 |
RAAJMEDI Cash Flow Statement — Operating, Investing & Financing
Raaj Medisafe operating cash flow ₹0 Cr, investing ₹-16 Cr, financing ₹17 Cr, net cash flow ₹0 Cr (2025).
| Particulars | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 | March 2019 | March 2018 | March 2017 | March 2016 | March 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 0 | 4 | 0 | 3 | 2 | -1 | -1 | 0 | 0 | 0 | 0 |
| Investing Activities | -16 | -13 | -2 | -1 | -3 | 0 | 0 | 0 | -1 | -1 | -2 |
| Financing Activities | 17 | 9 | 2 | -2 | 1 | 1 | 1 | 0 | 1 | 0 | 3 |
| Net Cash Flow | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |